Healthpeak Properties (NYSE:DOC) Issues FY 2025 Earnings Guidance

Healthpeak Properties (NYSE:DOC) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 1.810-1.870 for the period, compared to the consensus estimate of 1.860. The company issued revenue guidance of -.

Healthpeak Properties Stock Performance

NYSE DOC traded down $0.25 during midday trading on Monday, hitting $20.41. The company had a trading volume of 5,578,212 shares, compared to its average volume of 4,366,614. The firm has a fifty day simple moving average of $20.75 and a two-hundred day simple moving average of $21.55. Healthpeak Properties has a fifty-two week low of $16.01 and a fifty-two week high of $23.26. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93. The stock has a market cap of $14.27 billion, a price-to-earnings ratio of 43.42, a P/E/G ratio of 2.22 and a beta of 1.15.

Healthpeak Properties Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th will be issued a $0.305 dividend. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 5.98%. Healthpeak Properties’s dividend payout ratio is 255.32%.

Wall Street Analyst Weigh In

DOC has been the topic of a number of research reports. Wells Fargo & Company lowered their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 10th. StockNews.com cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Robert W. Baird lifted their target price on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a research report on Wednesday, January 15th. Finally, Royal Bank of Canada lifted their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $24.15.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.